Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 113 of 1,261
  1. US 12005123

    Conjugate of isotretinoin and peptide

    CAREGEN CO., LTD. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  2. US 12006294

    Therapeutic compounds

    Regents of the University of Minnesota · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  3. US 12006298

    Polymorphic compounds and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  4. US 12006321

    Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  5. US 12005074

    Extrahepatic delivery

    Alnylam Pharmaceuticals, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  6. US 12006340

    Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

    Atea Pharmaceuticals, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  7. US 12006517

    Method for purification of bacteriophage particles

    Adaptive Phage Therapeutics, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  8. US 12006522

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Precision BioSciences, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  9. US 12006516

    Differentiation of pancreatic endocrine cells

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  10. US 12006365

    Human anti-semaphorin 4D antibody

    VACCINEX, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  11. US 12006364

    Anti-CD100 antibodies and methods for using the same

    VACCINEX, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  12. US 12006363

    Anti-tetraspanin 33 agents and compositions and methods for making and using the same

    BioLegend, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  13. US 12006355

    Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

    The Regents of the University of California · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  14. US 12006348

    T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof

    Cue Biopharma, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  15. US 2024180883

    TREATMENT OF MIGRAINE

    ALLERGAN PHARMACEUTICALS INT LTD [IE] · Granted Jun 6, 2024 · Expires Jun 1, 2044

    granted
  16. IT 202200024963

    Composti attivatori dei canali potassio Kv7.2/Kv7.3

    ANGELINI PHARMA S P A [IT] · Granted Jun 5, 2024 · Expires May 31, 2044

    granted
  17. IT 202200024948

    Composti attivatori dei canali potassio KV7.2/KV7.3

    ANGELINI PHARMA S P A [IT] · Granted Jun 5, 2024 · Expires May 31, 2044

    granted
  18. US 11998589

    PEGylated peptide amphiphile nanofibers and methods of use

    Northwestern University · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  19. US 11998606

    Compounds and methods for selective proteolysis of glucocorticoid receptors

    The Board of Regents of the University of Texas System · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  20. US 11999683

    Lipocationic dendrimers and uses thereof

    The Board of Regents of the University of Texas System · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  21. US 11999693

    Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment

    The Regents of the University of California · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  22. US 11999773

    Anti-BCMA chimeric antigen receptors

    Cartesian Therapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  23. US 11998571

    Pharmaceutical composition comprising stem cell-conditioned medium and exosome isolated therefrom as active ingredient for prevention or treatment of ocular disease

    DESIGNED CELLS CO., LTD. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  24. US 11998568

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.